Navidea secures $7.5M from Cardinal Health

Immunodiagnostics and immunotherapy drug developer Navidea Biopharmaceutical...Read more on AuntMinnie.comRelated Reading: NYSE American notifies Navidea of listing noncompliance Navidea to sell $8M milestone payment Navidea posts deep Q3 revenue decreases FDA clears Cardinal's Lymphoseek for pediatric use Cardinal Health joins SNMMI's Value Initiative
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news